These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 25537527)

  • 1. Treatment for a eumycetoma infection caused by Aspergillus in an immunocompromised host: a case report.
    Hopps S; Roach A; Yuen C; Borders E
    Transpl Infect Dis; 2015 Feb; 17(1):94-7. PubMed ID: 25537527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seventeen years of subcutaneous infection by Aspergillus flavus; eumycetoma confirmed by immunohistochemistry.
    Ahmed SA; Abbas MA; Jouvion G; Al-Hatmi AM; de Hoog GS; Kolecka A; Mahgoub el S
    Mycoses; 2015 Dec; 58(12):728-34. PubMed ID: 26497138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First reported case of Aspergillus nidulans eumycetoma in a sporotrichoid distribution.
    Verma R; Vasudevan B; Sahni AK; Vijendran P; Neema S; Kharayat V
    Int J Dermatol; 2015 Jan; 54(1):74-7. PubMed ID: 25267555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspergillus: An uncommon pathogen of eumycetoma.
    Sawatkar GU; Narang T; Shiva Prakash MR; Daroach M; Sharma M; Nahar Saikia U; Dogra S
    Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27612290
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycetoma Caused by Aspergillus nidulans.
    Veraldi S; Grancini A; Venegoni L; Merlo V; Guanziroli E; Menicanit C; Nazzaro G; Tortorano A
    Acta Derm Venereol; 2016 Jan; 96(1):118-9. PubMed ID: 26014969
    [No Abstract]   [Full Text] [Related]  

  • 6. Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach.
    Ament AJ; Hübben MW; Verweij PE; de Groot R; Warris A; Donnelly JP; van 't Wout J; Severens JL
    J Antimicrob Chemother; 2007 Aug; 60(2):385-93. PubMed ID: 17561501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
    Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Guideline based treatment of invasive aspergillosis].
    Karthaus M
    Mycoses; 2010 May; 53 Suppl 1():36-43. PubMed ID: 20433655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of Scedosporium apiospermum soft tissue abscess with caspofungin and voriconazole in a severely immunocompromised patient with acute myeloid leukemia.
    Beier F; Kittan N; Holzmann T; Schardt K; Andreesen R; Holler E; Hildebrandt GC
    Transpl Infect Dis; 2010 Dec; 12(6):538-42. PubMed ID: 20604906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudallescheria boydii with Aspergillus fumigatus and Aspergillus terreus in a Critically Ill Hematopoietic Stem Cell Recipient with ARDS.
    Lahmer T; Messer M; Ehmer U; Eser S; Beitz A; Fekecs L; Schmid RM; Huber W
    Mycopathologia; 2016 Apr; 181(3-4):267-71. PubMed ID: 26455910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycetoma foot caused by Aspergillus in a diabetic patient.
    Kotwal N; Yanamandra U; Badwal S; Nair V
    Intern Med; 2012; 51(5):517-8. PubMed ID: 22382571
    [No Abstract]   [Full Text] [Related]  

  • 12. Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national survey.
    He SY; Makhzoumi ZH; Singer JP; Chin-Hong PV; Arron ST
    Transpl Infect Dis; 2015 Feb; 17(1):14-20. PubMed ID: 25620387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience with voriconazole in invasive aspergillosis].
    Thiel E; Schwartz S
    Mycoses; 2003; 46 Suppl 2():3-7. PubMed ID: 15055137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal amphotericin B (AmBisome) efficacy in confirmed invasive aspergillosis and other filamentous fungal infections in immunocompromised hosts: a pooled analysis.
    Cordonnier C; Bresnik M; Ebrahimi R
    Mycoses; 2007 May; 50(3):205-9. PubMed ID: 17472618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
    Herbrecht R; Denning DW; Patterson TF; Bennett JE; Greene RE; Oestmann JW; Kern WV; Marr KA; Ribaud P; Lortholary O; Sylvester R; Rubin RH; Wingard JR; Stark P; Durand C; Caillot D; Thiel E; Chandrasekar PH; Hodges MR; Schlamm HT; Troke PF; de Pauw B;
    N Engl J Med; 2002 Aug; 347(6):408-15. PubMed ID: 12167683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First case of breakthrough pulmonary Aspergillus niveus infection in a patient after allogeneic hematopoietic stem cell transplantation.
    Auberger J; Lass-Flörl C; Clausen J; Bellmann R; Buzina W; Gastl G; Nachbaur D
    Diagn Microbiol Infect Dis; 2008 Nov; 62(3):336-9. PubMed ID: 18687556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Aspergillus osteomyelitis: report of failure of liposomal amphotericin B and response to voriconazole in an immunocompetent host and literature review.
    Stratov I; Korman TM; Johnson PD
    Eur J Clin Microbiol Infect Dis; 2003 May; 22(5):277-83. PubMed ID: 12734721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive Aspergillosis: Epidemiology, Clinical Aspects, and Treatment.
    Gregg KS; Kauffman CA
    Semin Respir Crit Care Med; 2015 Oct; 36(5):662-72. PubMed ID: 26398533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant.
    Klein KC; Blackwood RA
    Pediatrics; 2006 Aug; 118(2):e506-8. PubMed ID: 16816005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive mould infections in the ICU setting: complexities and solutions.
    Bassetti M; Bouza E
    J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i39-i47. PubMed ID: 28355466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.